FMR LLC - 30 Sep 2025 SCHEDULE 13G/A Report for VIKING THERAPEUTICS INC COMMON STOCK (VKTX)

Reporting parties 2 facts
Subject security 3 facts
Symbol
VKTX
Shares outstanding
113,177,462 shares
Ownership signal 2 facts
SEC evidence 5 facts
Form type
SCHEDULE 13G/A
Filing time
05 Nov 2025, 11:49:28 UTC
Event date
30 Sep 2025
Previous filing
06 Aug 2025
SEC filing
View on sec.gov

Key filing fact

FMR LLC disclosed 5.1% ownership in VIKING THERAPEUTICS INC COMMON STOCK (VKTX) on 30 Sep 2025.

Key facts

  • FMR LLC filed SCHEDULE 13G/A for VIKING THERAPEUTICS INC COMMON STOCK (VKTX).
  • Disclosed ownership: 5.1%.
  • Date of event: 30 Sep 2025.

Change

  • Previous schedule filing date: 06 Aug 2025.
  • Current filing was accepted on 05 Nov 2025, 11:49.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (2)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
FMR LLC 5.1% 5,772,051 5,724,561 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson 5.1% 5,772,051 0 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .